PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VIVA Biotech Holdings (1873.HK)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINKYG9390W1015
SectorHealthcare
IndustryBiotechnology

Highlights

Market CapHK$1.20B
Revenue (TTM)HK$2.16B
Gross Profit (TTM)HK$650.98M
EBITDA (TTM)HK$363.06M
Year RangeHK$0.41 - HK$2.00
Target PriceHK$7.95

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


VIVA Biotech Holdings

Performance

Performance Chart

The chart shows the growth of an initial investment of HK$10,000 in VIVA Biotech Holdings, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%100.00%December2024FebruaryMarchAprilMay
-86.11%
75.61%
1873.HK (VIVA Biotech Holdings)
Benchmark (^GSPC)

S&P 500

Returns By Period

VIVA Biotech Holdings had a return of -41.90% year-to-date (YTD) and -57.34% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-41.90%6.17%
1 month17.31%-2.72%
6 months-51.59%17.29%
1 year-57.34%23.80%
5 years (annualized)N/A11.47%
10 years (annualized)N/A10.41%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2024-39.05%-7.81%-8.47%-1.85%
20231.59%-10.94%-7.89%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of 1873.HK is 8, indicating that it is in the bottom 8% of the market in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of 1873.HK is 88
VIVA Biotech Holdings(1873.HK)
The Sharpe Ratio Rank of 1873.HK is 66Sharpe Ratio Rank
The Sortino Ratio Rank of 1873.HK is 66Sortino Ratio Rank
The Omega Ratio Rank of 1873.HK is 88Omega Ratio Rank
The Calmar Ratio Rank of 1873.HK is 1212Calmar Ratio Rank
The Martin Ratio Rank of 1873.HK is 99Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for VIVA Biotech Holdings (1873.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


1873.HK
Sharpe ratio
The chart of Sharpe ratio for 1873.HK, currently valued at -0.94, compared to the broader market-2.00-1.000.001.002.003.004.00-0.94
Sortino ratio
The chart of Sortino ratio for 1873.HK, currently valued at -1.60, compared to the broader market-4.00-2.000.002.004.006.00-1.60
Omega ratio
The chart of Omega ratio for 1873.HK, currently valued at 0.82, compared to the broader market0.501.001.500.82
Calmar ratio
The chart of Calmar ratio for 1873.HK, currently valued at -0.65, compared to the broader market0.002.004.006.00-0.65
Martin ratio
The chart of Martin ratio for 1873.HK, currently valued at -1.39, compared to the broader market-10.000.0010.0020.0030.00-1.39
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 1.97, compared to the broader market-2.00-1.000.001.002.003.004.001.97
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.84, compared to the broader market-4.00-2.000.002.004.006.002.84
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.34, compared to the broader market0.501.001.501.34
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.50, compared to the broader market0.002.004.006.001.50
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 7.61, compared to the broader market-10.000.0010.0020.0030.007.61

Sharpe Ratio

The current VIVA Biotech Holdings Sharpe ratio is -0.94. This value is calculated based on the past 12 months of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of VIVA Biotech Holdings with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00December2024FebruaryMarchAprilMay
-0.94
1.93
1873.HK (VIVA Biotech Holdings)
Benchmark (^GSPC)

Dividends

Dividend History

VIVA Biotech Holdings granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.00 per share.


PeriodTTM20232022202120202019
DividendHK$0.00HK$0.00HK$0.00HK$0.01HK$0.03HK$0.01

Dividend yield

0.00%0.00%0.00%0.21%0.35%0.11%

Monthly Dividends

The table displays the monthly dividend distributions for VIVA Biotech Holdings. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2024HK$0.00HK$0.00HK$0.00HK$0.00
2023HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.01HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.02HK$0.00HK$0.00HK$0.00
2019HK$0.01HK$0.00HK$0.00HK$0.00

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%December2024FebruaryMarchAprilMay
-94.51%
-3.79%
1873.HK (VIVA Biotech Holdings)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the VIVA Biotech Holdings. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the VIVA Biotech Holdings was 96.27%, occurring on Apr 19, 2024. The portfolio has not yet recovered.

The current VIVA Biotech Holdings drawdown is 94.51%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-96.27%Jun 24, 2021695Apr 19, 2024
-41.96%Aug 10, 2020173Apr 22, 202124May 27, 2021197
-37.84%May 16, 201928Jun 25, 2019219May 13, 2020247
-24.27%Jul 10, 20205Jul 16, 202014Aug 5, 202019
-13.67%May 22, 20201May 22, 20202May 26, 20203

Volatility

Volatility Chart

The current VIVA Biotech Holdings volatility is 27.39%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%December2024FebruaryMarchAprilMay
27.39%
4.06%
1873.HK (VIVA Biotech Holdings)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of VIVA Biotech Holdings over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items